Actively Recruiting

Age: 65Years +
All Genders
NCT05677646

Wearable Sensors for Delirium Detection at an Early Stage (WeSen_delirium)

Led by University of Zurich · Updated on 2024-05-10

72

Participants Needed

2

Research Sites

148 weeks

Total Duration

On this page

Sponsors

U

University of Zurich

Lead Sponsor

K

Klinik Hirslanden, Zurich

Collaborating Sponsor

AI-Summary

What this Trial Is About

Delirium is an acute brain-organic syndrome: its clinical manifestation and form are results of a highly complex pathophysiology. Delirium is a serious clinical problem in hospitalized adults. It is the most common neuropsychiatric complication of hospitalization and is associated with high patient burden, increased morbidity and mortality, prolonged length of stay, higher costs, and institutionalization. An early, accurate diagnosis as well as an adequate management are critical to the continued health and functional independence of the affected patients. Prevention strategies contain pharmacological and non-pharmacological interventions. However, their clinical success (effectiveness) is limited and the evidence for the use of pharmacological interventions for the prevention or management of delirium is scarce. The prediction of delirium has become a new promising topic in clinical research. New approaches like the implementation of wearable sensors, in particular wearable accelerometer devices to record movements related to delirium are promising. In this study, the study procedure only includes wearing a consumer-grade sensor on the wrist of the not-dominant hand. This way, vital parameters are measured in order to identify patterns.

CONDITIONS

Official Title

Wearable Sensors for Delirium Detection at an Early Stage (WeSen_delirium)

Who Can Participate

Age: 65Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Female and male inpatients aged 65 years or older
  • Cognitive ability to understand, consent to and participate in the study
  • Fluent in German
  • Provision of written informed consent
Not Eligible

You will not qualify if you...

  • Presence of acute delirium
  • Delirium diagnosis made within the last 4 weeks prior to hospitalization
  • Likelihood of an alcohol withdrawal delirium (CAGE Score >1)
  • Limited knowledge of the German language
  • Dementia with Mini Mental Status Test Score 24 or lower

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Klinik Hirslanden

Zurich, Switzerland

Actively Recruiting

2

University Hospital Zurich, Internal Medicine

Zurich, Switzerland

Actively Recruiting

Loading map...

Research Team

M

Martina Kleber, PD Dr.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here